Walleye Capital LLC Standard Biotools Inc. Transaction History

Walleye Capital LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.65 - $2.92 $926,509 - $1.64 Million	561,521 New	561,521 $993,000
Q2 2023 Aug 14, 2023	BUY	$1.47 - $2.56 $30,186 - $52,569	20,535 New	20,535 $39,000
Q2 2022 Aug 08, 2022	BUY	$1.6 - $3.99 $27,948 - $69,697	17,468 New	17,468 $28,000
Q3 2020 Nov 16, 2020	SELL	$4.34 - $11.43 $48,143 - $126,792	-11,093 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$1.85 - $5.29 $294,906 - $843,273	-159,409 Reduced 93.49%	11,093 $44,000
Q1 2020 May 15, 2020	BUY	$1.24 - $4.35 $52,595 - $184,509	42,416 Added 33.12%	170,502 $433,000
Q4 2019 Feb 14, 2020	BUY	$2.3 - $5.12 $294,597 - $655,800	128,086 New	128,086 $446,000
Q2 2019 Aug 14, 2019	SELL	$11.49 - $14.17 $168,903 - $208,299	-14,700 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$8.47 - $14.36 $124,509 - $211,092	14,700 New	14,700 $195,000

143

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $132M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.